Expanding innovative portfolio may drive gains for Sun Pharma stock

1778031943 5688



Lerodalcibep licensing deal, growth in the US portfolio and tariff relief offer triggers, while the proposed Organon acquisition could broaden its global reach



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *